The Investor
05 Nov 2026, 14:54
Cigna Rises 1.5% as Q3 Revenue Grows and 2026 Earnings Outlook Increases
The Cigna Group (NYSE: CI) shares rose about 1.5% after the company reported higher third-quarter revenue and raised its full-year adjusted earnings outlook.
Third-quarter revenue increased 6% year over year to $73.7 billion, while adjusted income from operations was $2.1 billion, or $7.98 per share, compared with $7.83 per share a year earlier. :chatgpt-content-reference{index="0"}
Reported net income fell to $1.4 billion, or $5.47 per share, from $1.9 billion a year earlier, largely reflecting the absence of a prior-year gain on sale. :chatgpt-content-reference{index="1"}
Cigna Healthcare delivered stronger results, with adjusted revenue up 9% and adjusted pre-tax operating income up 15%. Evernorth adjusted revenue rose 6%, although pre-tax operating income declined 4% as Pharmacy Benefit Services profit fell 22%. :chatgpt-content-reference{index="2"} :chatgpt-content-reference{index="3"}
The company raised its 2026 adjusted EPS outlook to at least $30.60, up $0.15 from its prior projection. :chatgpt-content-reference{index="4"}
The 1.5% share gain appears to reflect the higher earnings outlook and solid growth in Cigna Healthcare, despite softer profitability in the pharmacy benefit business.
The Cigna Group (NYSE: CI) shares rose about 1.5% after the company reported higher third-quarter revenue and raised its full-year adjusted earnings outlook.
Third-quarter revenue increased 6% year over year to $73.7 billion, while adjusted income from operations was $2.1 billion, or $7.98 per share, compared with $7.83 per share a year earlier. :chatgpt-content-reference{index="0"}
Reported net income fell to $1.4 billion, or $5.47 per share, from $1.9 billion a year earlier, largely reflecting the absence of a prior-year gain on sale. :chatgpt-content-reference{index="1"}
Cigna Healthcare delivered stronger results, with adjusted revenue up 9% and adjusted pre-tax operating income up 15%. Evernorth adjusted revenue rose 6%, although pre-tax operating income declined 4% as Pharmacy Benefit Services profit fell 22%. :chatgpt-content-reference{index="2"} :chatgpt-content-reference{index="3"}
The company raised its 2026 adjusted EPS outlook to at least $30.60, up $0.15 from its prior projection. :chatgpt-content-reference{index="4"}
The 1.5% share gain appears to reflect the higher earnings outlook and solid growth in Cigna Healthcare, despite softer profitability in the pharmacy benefit business.